Perspectives of stem cell therapy in Duchenne muscular dystrophy

Muscular dystrophies are heritable and heterogeneous neuromuscular disorders characterized by the primary wasting of skeletal muscle, usually caused by mutations in the proteins forming the link between the cytoskeleton and the basal lamina. As a result of mutations in the dystrophin gene, Duchenne...

Full description

Saved in:
Bibliographic Details
Published in:The FEBS journal 2013-09, Vol.280 (17), p.4251-4262
Main Authors: Meregalli, Mirella, Farini, Andrea, Belicchi, Marzia, Parolini, Daniele, Cassinelli, Letizia, Razini, Paola, Sitzia, Clementina, Torrente, Yvan
Format: Article
Language:English
Subjects:
Animals
Cell- and Tissue-Based Therapy
Cellular biology
Duchenne muscular dystrophy
Humans
Muscular dystrophy
Muscular Dystrophy, Duchenne - metabolism
Muscular Dystrophy, Duchenne - therapy
Mutation
Proteins
Stem Cell Transplantation
Stem cells
Stem Cells - cytology
Stem Cells - metabolism
therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Muscular dystrophies are heritable and heterogeneous neuromuscular disorders characterized by the primary wasting of skeletal muscle, usually caused by mutations in the proteins forming the link between the cytoskeleton and the basal lamina. As a result of mutations in the dystrophin gene, Duchenne muscular dystrophy patients suffer from progressive muscle atrophy and an exhaustion of muscular regenerative capacity. No efficient therapies are available. The evidence that adult stem cells were capable of participating in the regeneration of more than their resident organ led to the development of potential stem cell treatments for degenerative disorder. In the present review, we describe the different types of myogenic stem cells and their possible use for the progression of cell therapy in Duchenne muscular dystrophy. Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy and unfortunately no effective therapy is available at present. As stem cells received much attention for their potential use in cell‐based therapies for human diseases, herein we described multiple types of resident and circulating myogenic stem cells, their characterization and their possible use to treat muscular dystrophies.
ISSN:1742-464X
1742-4658
DOI:10.1111/febs.12083